<DOC>
	<DOCNO>NCT01072344</DOCNO>
	<brief_summary>Prior research show chamomile may effective , short-term anti-anxiety treatment . This study examine initial long-term benefit chamomile extract therapy prevention recurrent anxiety disorder .</brief_summary>
	<brief_title>Long Term Chamomile Therapy Anxiety</brief_title>
	<detailed_description>Anxiety disorder among common psychiatric condition . They affect 25 % US adult population . Generalized anxiety disorder ( GAD ) chronic , recurrent form disorder . Although benzodiazepine serotonin reuptake inhibitor become mainstay therapy GAD , drug often associate unwanted side effect , habituation , withdrawal symptom . Many individual decline use conventional drug therapy financial , cultural , personal reason stigma mental illness . As result , many individual seek alternative therapy anxiety symptom . The identification effective alternative therapy GAD would particular relevance . Among alternative therapy anxiety , chamomile use traditional herbal medicine calm effect . It well tolerate demonstrates pharmacological activity animal model anxiety . Despite widespread use availability , one clinical trial chamomile safety efficacy GAD . The current application seek build upon result prior chamomile study . In 8-week , double-blind , placebo-controlled trial , find significant superiority chamomile ( vs. placebo ) reduce GAD symptom . We also find chamomile exceedingly well tolerate ( vs. placebo ) . The current application seek extend promise preliminary result conduct randomized , double-blind , parallel group , placebo-substitution , long-term safety efficacy study chamomile prevent GAD relapse . For specific aim # 1 ask : `` Does long-term chamomile therapy ( vs. placebo ) prolong time relapse anxiety symptom follow recovery GAD ? '' To answer question , 180 patient moderate severe GAD receive open-label chamomile extract 500-1,500 mg daily 8 week . Responders chamomile , remain well 4 additional week consolidation therapy , randomize double-blind continuation therapy chamomile 500-1,500 mg daily placebo additional 26 week . We hypothesize continuation chamomile therapy result prolong time relapse ( vs. placebo ) . For specific aim # 2 ask : `` What relative safety tolerability long-term chamomile therapy ( vs. placebo ) patient recover GAD ? '' To answer question , examine follow outcome measure : ( ) proportion patient treatment condition relapse ; ( ii ) frequency , severity , duration treatment-emergent adverse event ; ( iii ) frequency discontinuation symptom initial double-blind therapy ; , ( iv ) frequency early study discontinuation . We hypothesize chamomile therapy result low proportion anxiety relapse low study discontinuation rate ( vs. placebo ) . We hypothesize chamomile therapy result similar frequency discontinuation symptom treatment-emergent adverse event ( vs. placebo ) .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Men woman least 18 year old ( race ethnicity ) DSM IV diagnosis GAD primary anxiety disorder Baseline GAD7 score â‰¥ 10 Baseline CGI/S score least 4 Not take antianxiety medication ( e.g. , Benzodiazepines , buspirone , antidepressant ) Not take antidepressant , mood stabilizer , tranquilizer therapy prior DSM IV Axis I mood disorder remission Able understand provide inform consent Able participate 38week study Patients &lt; 18 year old Primary DSM IV Axis I anxiety disorder GAD ( e.g. , panic disorder without agoraphobia , phobia disorder , acute stress disorder , social anxiety disorder , obsessivecompulsive disorder , posttraumatic stress disorder , substanceinduced anxiety disorder ) Current DSM IV Axis I psychotic disorder Substance abuse dependence within prior 3 month Current DSM IV Axis I bipolar major depressive disorder [ Note : Patients comorbid depressive disorder NOS ( e.g. , minor depression , recurrent brief depressive disorder , premenstrual dysphoric disorder ( PMDD ) ] exclude Unstable medical condition Allergy chamomile Documented allergy plant asteraceae family ( e.g. , ragweed , aster , chrysanthemum ) Allergic mugwort birch pollen Concurrent antianxiety tranquilizer , antidepressant mood stabilizer therapy Concurrent use overthecounter antianxiety and/or antidepressant preparation ( e.g. , chamomile , St. John 's Wort , kava kava ) Concurrent use establish antidepressant , mood stabilizer , tranquilizer therapy preexist affective disorder . [ Note : Patients history affective disorder ( remission ) currently take antidepressant , mood stabilizer , tranquilizer therapy exclude trial ] Women childbearing potential willing use medically proven form contraception Positive pregnancy test Actively suicidal suicide attempt within precede 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Anxiety</keyword>
	<keyword>Chamomile</keyword>
	<keyword>Herbal Remedy</keyword>
	<keyword>Complementary Alternative Medicine</keyword>
</DOC>